A partnership was formed between Intel and Oregon Health & Science University to design computing tools that will speed up and boost the accuracy of examining the genetic profiles of patients. "By combining Intel's computing expertise with what we know about how to analyze genomes and to create images of how cells change over time, we believe we have the capability to develop the right tools to make significant progress in making the promise of personalized cancer medicine a reality for more patients," said Joe Gray, associate director for translational research at OHSU's Knight Cancer Institute.

Related Summaries